← Open Payments lookup

NANCY GRAVES: Open Payments

NPI 1013138361 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,420 in 173 payments from 18 companies in 2025. Trend: 2023 $2,546 · 2024 $1,158 · 2025 $3,420

Food & beverage: $3,365Education: $55
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.42$843
ABBVIE INC.26$586
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)32$501
Vanda Pharmaceuticals Inc.17$308
HARMONY BIOSCIENCES LLC7$232
Teva Pharmaceuticals USA, Inc.8$226
Lundbeck LLC12$162
Neurocrine BioSciences, Inc.5$101
E.R. Squibb & Sons, L.L.C.5$92
Takeda Pharmaceuticals U.S.A., Inc.5$83

Products named: REXULTI, VRAYLAR, CAPLYTA, FANAPT, WAKIX, AUSTEDO XR, INGREZZA, COBENFY.

Industry payments across TX — which companies pay providers there.